Accelerated rTMS: A Potential Treatment Approach to Alleviate Depression?

Presenting: Accelerated rTMS: A Potential Treatment Approach to Alleviate Depression?

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:
Accelerated rTMS: A Potential Treatment Approach to Alleviate Depression?

Learning objectives: 

1.     Learners will know the most updated literature on accelerated rTMS paradigms and major depression.

2.     Learners will have better insights on the neurobiological effects of accelerated rTMS protocols applied in depressed patients.

3.     Learners will be able to state the risks and benefits of accelerated rTMS and accelerated iTBS paradigms for (treatment-resistant) major depression.

4.     Learners will be able to have improved risk and benefit discussions with (treatment-resistant) depressed patients who are interested in rTMS treatment.

Date: Tuesday, January 15, 2019

Format: On-Demand

Cost: Members: $25 | Non-members $50

Speakers: Chris Baeken, MD, PhD

Chris Baeken, MD, PhD is full time associate professor at the University hospital of the Ghent University, and he is part-time associate professor affiliated with the University hospital of the Free University of Brussels, both in Belgium. As a psychiatrist his main interests are within the neurobiological field of Affective Disorders. To gain more insight in the underlying mechanisms of emotional brain processes in the ‘healthy’ as well as in the ‘mentally affected’ human brain, brain-imaging paradigms (MRI, fMRI, (S)PET,….) are used with or without the combination of neuromodulation techniques, such as rTMS and tDCS. His scientific contributions to clinical neuroscience is shown by over 200 peer-refereed scientific publications, mainly on clinical treatment, brain stimulation and neurobiology. His work has received very high international recognition from peers as can be judged from over 3000 citations to his work and an H-index of 32 (Google Scholar).

Credit Designation Statement
Amedco designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco and the Clinical TMS Society. Amedco is accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the America Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.